$44.1 Billion Deal Makes Merck Number Two U.S. Pharma Big pharma produced not one, but two mega-deals during the first quarter of 2009. In the most recent one, Merck & Co. (NYSE: MRK) announced that it is paying approximately $44.1 billion to buy rival...
FOR IMMEDIATE RELEASE Stephen M. Monroe, Partner Sanford B. Steever, Editor 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com NORWALK, CT – March 26, 2009 – Merger and acquisition activity in the health care industry’s service...
Eleven Deals Announced Worth $2.3 Billion After languishing in second or third place for the past few months, the Medical Device sector emerged as the single most active sector in February’s health care merger and acquisition market, posting 11 transactions worth a...
Recent Dealmaking Influenced By Cash Considerations Cash is king proved to be a dominant theme in February’s health care M&A market: how to keep it, how to raise it and how to use it wisely. Some companies swapped products so they wouldn’t have to dig into cash...
Seventy-One Deals Announced Worth $73.6 Billion The merger and acquisition market in the health care industry for January 2009 posted a total of 71 deals, with transactions announced in each of the 13 sectors of the industry that we cover. Out of this amount, 43...
Acquisition Enlarges Biotech Pipeline And Revenues After several quarters of somewhat mall and dilatory acquisitions, Pfizer (NYSE: PFE) made a major announcement at the end of January. The company is buying competitor Wyeth (NYSE: WYE) for $68.0 billion. In doing...